n(6)-carboxymethyllysine has been researched along with telmisartan in 1 studies
Studies (n(6)-carboxymethyllysine) | Trials (n(6)-carboxymethyllysine) | Recent Studies (post-2010) (n(6)-carboxymethyllysine) | Studies (telmisartan) | Trials (telmisartan) | Recent Studies (post-2010) (telmisartan) |
---|---|---|---|---|---|
803 | 44 | 365 | 1,930 | 480 | 1,038 |
Protein | Taxonomy | n(6)-carboxymethyllysine (IC50) | telmisartan (IC50) |
---|---|---|---|
Cytochrome P450 2C9 | Homo sapiens (human) | 0.42 | |
Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0179 | |
Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0003 | |
Cytochrome P450 2J2 | Homo sapiens (human) | 0.5 | |
Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 1.2589 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.8621 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akizawa, T; Aoshima, Y; Hirai, Y; Honda, H; Hosaka, N; Michihata, T | 1 |
1 trial(s) available for n(6)-carboxymethyllysine and telmisartan
Article | Year |
---|---|
Olmesartan medoxomil is associated with decreased plasma AGEs, pentosidine, and N-(epsilon)-carboxymethyl-lysine levels in hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Arginine; Benzimidazoles; Benzoates; Blood Pressure; Female; Glycation End Products, Advanced; Humans; Hypertension, Renal; Imidazoles; Inflammation; Kidney Failure, Chronic; Lysine; Male; Olmesartan Medoxomil; Oxidative Stress; Pilot Projects; Prospective Studies; Renal Dialysis; Telmisartan; Tetrazoles; Treatment Outcome | 2012 |